Paradigms for dual antiplatelet therapy after PCI challenged by PARIS trial
Monday, September 2, 2013 - 12:00
in Health & Medicine
New study results show among patients undergoing percutaneous coronary intervention (PCI) with stents, the risk of cardiovascular complications after stopping dual antiplatelet therapy (DAPT) is highly variable depending on the context, and some patients experience no complications at all.